Vivani Medical Inc
NASDAQ:VANI
Operating Margin
Vivani Medical Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Vivani Medical Inc
NASDAQ:VANI
|
61m USD | N/A | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
225.9B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
185.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.7B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.9B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.5B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.3B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
38.5B USD |
29%
|
Vivani Medical Inc
Glance View
Vivani Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Emeryville, California and currently employs 15 full-time employees. The company went IPO on 2014-11-19. Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The firm is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The firm's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The firm's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Vivani Medical Inc's most recent financial statements, the company has Operating Margin of 0%.
You don't have any saved screeners yet